The encephalitogenic, human myelin oligodendrocyte glycoprotein-induced antibody repertoire is directed toward multiple epitopes in C57BL/6-immunized mice

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1091-1101

  Bansal, Pankaj ^a   Khan, Tarique ^a   Bussmeyer, Uta ^a   Challa, Dilip K ^a   Swiercz, Rafal ^a   Velmurugan, Ramraj ^a   Ober, Raimund J ^a,b   Ward, E Sally ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b The University of Texas at Dallas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE EXACERBATION; FEMALE; HUMORAL IMMUNITY; HYBRIDOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; FEMALE; HUMANS; IMMUNIZATION; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OLIGODENDROGLIA; SURFACE PLASMON RESONANCE;

EID: 84880684590     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300019     Document Type: Article

References (59)

1. Popescu, B. F., and C. F. Lucchinetti. 2012. Pathology of demyelinating diseases. Annu. Rev. Pathol. 7: 185-217.
2. Hafler, D. A., J. M. Slavik, D. E. Anderson, K. C. O'Connor, P. De Jager, and C. Baecher-Allan. 2005. Multiple sclerosis. Immunol. Rev. 204: 208-231.
3. Menge, T., H. C. von Büdingen, P. H. Lalive, and C. P. Genain. 2007. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA. Eur. J. Immunol. 37: 3229-3239.
4. Menge, T., P. H. Lalive, H. C. von Büdingen, and C. P. Genain. 2011. Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis. J. Neuroinflammation 8: 161.
5. Brunner, C., H. Lassmann, T. V. Waehneldt, J. M. Matthieu, and C. Linington. 1989. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 29,39-cyclic nucleotide 39-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52: 296-304.
6. Johns, T. G., and C. C. Bernard. 1999. The structure and function of myelin oligodendrocyte glycoprotein. J. Neurochem. 72: 1-9.
7. Breithaupt, C., B. Schäfer, H. Pellkofer, R. Huber, C. Linington, and U. Jacob. 2008. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. J. Immunol. 181: 1255-1263.
8. Zhou, D., R. Srivastava, S. Nessler, V. Grummel, N. Sommer, W. Brück, H. P. Hartung, C. Stadelmann, and B. Hemmer. 2006. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103: 19057-19062.
9. Berger, T., P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, and M. Reindl. 2003. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 349: 139-145.
10. Reindl, M., M. Khalil, and T. Berger. 2006. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 180: 50-62.
11. von Büdingen, H.-C., S. L. Hauser, A. Fuhrmann, C. B. Nabavi, J. I. Lee, and C. P. Genain. 2002. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. USA 99: 8207-8212.
12. O'Connor, K. C., H. Appel, L. Bregoli, M. E. Call, I. Catz, J. A. Chan, N. H. Moore, K. G. Warren, S. J. Wong, D. A. Hafler, and K. W. Wucherpfennig. 2005. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol. 175: 1974-1982.
13. Owens, G. P., J. L. Bennett, H. Lassmann, K. C. O'Connor, A. M. Ritchie, A. Shearer, C. Lam, X. Yu, M. Birlea, C. DuPree, et al. 2009. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann. Neurol. 65: 639-649.
14. Cameron, E. M., S. Spencer, J. Lazarini, C. T. Harp, E. S. Ward, M. Burgoon, G. P. Owens, M. K. Racke, J. L. Bennett, E. M. Frohman, and N. L. Monson. 2009. Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J. Neuroimmunol. 213: 123-130.
15. Lalive, P. H., T. Menge, C. Delarasse, B. Della Gaspera, D. Pham-Dinh, P. Villoslada, H. C. von Büdingen, and C. P. Genain. 2006. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103: 2280-2285.
16. Gaertner, S., K. L. de Graaf, B. Greve, and R. Weissert. 2004. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis. Neurology 63: 2381-2383.
17. Linnington, C., M. Webb, and P. L. Woodhams. 1984. A novel myelin-Associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6: 387-396.
18. Brehm, U., S. J. Piddlesden, M. V. Gardinier, and C. Linington. 1999. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 97: 9-15.
19. Bourquin, C., A. Iglesias, T. Berger, H. Wekerle, and C. Linington. 2000. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 30: 3663-3671.
20. Piddlesden, S. J., H. Lassmann, F. Zimprich, B. P. Morgan, and C. Linington. 1993. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143: 555-564.
21. Schluesener, H. J., R. A. Sobel, C. Linington, and H. L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139: 4016-4021.
22. Marta, C. B., A. R. Oliver, R. A. Sweet, S. E. Pfeiffer, and N. H. Ruddle. 2005. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl. Acad. Sci. USA 102: 13992-13997.
23. Pöllinger, B., G. Krishnamoorthy, K. Berer, H. Lassmann, M. R. Bö sl, R. Dunn, H. S. Domingues, A. Holz, F. C. Kurschus, and H. Wekerle. 2009. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 206: 1303-1316.
24. Lyons, J. A., M. San, M. P. Happ, and A. H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29: 3432-3439.
25. Hjelmström, P., A. E. Juedes, J. Fjell, and N. H. Ruddle. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161: 4480-4483.
26. Bourquin, C., A. Schubart, S. Tobollik, I. Mather, S. Ogg, R. Liblau, and C. Linington. 2003. Selective unresponsiveness to conformational B cell epitopes of the myelin oligodendrocyte glycoprotein in H-2b mice. J. Immunol. 171: 455-461.
27. Oliver, A. R., G. M. Lyon, and N. H. Ruddle. 2003. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171: 462-468.
28. Lyons, J. A., M. J. Ramsbottom, and A. H. Cross. 2002. Critical role of antigenspecific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32: 1905-1913.
29. Storch, M. K., S. Piddlesden, M. Haltia, M. Iivanainen, P. Morgan, and H. Lassmann. 1998. Multiple sclerosis: in situ evidence for antibody-And complement-mediated demyelination. Ann. Neurol. 43: 465-471.
30. Raine, C. S., B. Cannella, S. L. Hauser, and C. P. Genain. 1999. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46: 144-160.
31. Lucchinetti, C., W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47: 707-717.
32. Marta, C. B., M. B. Montano, C. M. Taylor, A. L. Taylor, R. Bansal, and S. E. Pfeiffer. 2005. Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. J. Biol. Chem. 280: 8985-8993.
33. Marta, C. B., C. M. Taylor, T. Coetzee, T. Kim, S. Winkler, R. Bansal, and S. E. Pfeiffer. 2003. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J. Neurosci. 23: 5461-5471.
34. Breithaupt, C., A. Schubart, H. Zander, A. Skerra, R. Huber, C. Linington, and U. Jacob. 2003. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc. Natl. Acad. Sci. USA 100: 9446-9451.
35. Amit, A. G., R. A. Mariuzza, S. E. Phillips, and R. J. Poljak. 1986. Threedimensional structure of an antigen-Antibody complex at 2.8 Aresolution. Science 233: 747-753.
36. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68.
37. Devaux, B., F. Enderlin, B. Wallner, and D. E. Smilek. 1997. Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. J. Neuroimmunol. 75: 169-173.
38. Radu, C. G., S. M. Anderton, M. Firan, D. C. Wraith, and E. S. Ward. 2000. Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. Int. Immunol. 12: 1553-1560.
39. Yokoyama, W. M., M. Christensen, G.D. Santos, and D. Miller. 2006. Production of monoclonal antibodies. Curr. Protoc.Immunol. 2.5.1-2.5.25.
40. Foote, J., and G. Winter. 1992. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224: 487-499.
41. Kabat, E. A., T. T. Wu, H. M. Perry, K. S. Gottesman, and C. Foeller. 1991. Sequences of Proteins of Immunological Interest, 5th ed. Bethesda, MD. U.S. Department of Health and Human Services.
42. Ward, E. S., D. Güssow, A. D. Griffiths, P. T. Jones, and G. Winter. 1989. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 341: 544-546.
43. Clackson, T., H. R. Hoogenboom, A. D. Griffiths, and G. Winter. 1991. Making antibody fragments using phage display libraries. Nature 352: 624-628.
44. Ward, E. S. 1995. VH shuffling can be used to convert an Fv fragment of antihen egg lysozyme specificity to one that recognizes a T cell receptor V alpha. Mol. Immunol. 32: 147-156.
45. Krebber, A., S. Bornhauser, J. Burmester, A. Honegger, J. Willuda, H. R. Bosshard, and A. Plückthun. 1997. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J. Immunol. Methods 201: 35-55.
46. Ober, R. J., and E. S. Ward. 2002. Compensation for loss of ligand activity in surface plasmon resonance experiments. Anal. Biochem. 306: 228-236.
47. Zhou, J., F. Mateos, R. J. Ober, and E. S. Ward. 2005. Conferring the binding properties of the mouse MHC class I-related receptor, FcRn, onto the human ortholog by sequential rounds of site-directed mutagenesis. J. Mol. Biol. 345: 1071-1081.
48. Minguela, A., S. Pastor, W. Mi, J. A. Richardson, and E. S. Ward. 2007. Feedback regulation of murine autoimmunity via dominant anti-inflammatory effects of interferon gamma. J. Immunol. 178: 134-144.
49. Ober, R. J., C. Martinez, C. Vaccaro, J. Zhou, and E. S. Ward. 2004. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J. Immunol. 172: 2021-2029.
50. Haase, C. G., J. Guggenmos, U. Brehm, M. Andersson, T. Olsson, M. Reindl, J. M. Schneidewind, U. K. Zettl, F. Heidenreich, T. Berger, et al. 2001. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114: 220-225.
51. Mela, A., and J. E. Goldman. 2009. The tetraspanin KAI1/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination. J. Neurosci. 29: 11172-11181.
52. Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310: 1510-1512.
53. Duncan, A. R., and G. Winter. 1988. The binding site for C1q on IgG. Nature 332: 738-740.
54. Lassmann, H., W. Brück, and C. Lucchinetti. 2001. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7: 115-121.
55. Barnett, M. H., J. D. Parratt, E. S. Cho, and J. W. Prineas. 2009. Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann. Neurol. 65: 32-46.
56. Nimmerjahn, F., P. Bruhns, K. Horiuchi, and J. V. Ravetch. 2005. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 23: 41-51.
57. Nimmerjahn, F., and J. V. Ravetch. 2006. Fcgamma receptors: old friends and new family members. Immunity 24: 19-28.
58. Radeke, H. H., I. Janssen-Graalfs, E. N. Sowa, N. Chouchakova, J. Skokowa, F. Löscher, R. E. Schmidt, P. Heeringa, and J. E. Gessner. 2002. Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J. Biol. Chem. 277: 27535-27544.
59. O'Connor, K. C., T. Chitnis, D. E. Griffin, S. Piyasirisilp, A. Bar-Or, S. Khoury, K. W. Wucherpfennig, and D. A. Hafler. 2003. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-Affinity interactions. J. Neuroimmunol. 136: 140-148.